Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overall Survival, OS”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Not applicableStudy completedNCT05954546
What this trial is testing

Compare How Effective is Encorafenib Plus Binimetinib in Real-world and Clinical Trial Settings

Who this might be right for
Metastatic Melanoma
Pfizer 275
Not applicableStudy completedNCT03969550
What this trial is testing

Do CCR5 Antagonists Improve the Overall Survival of Patients With AIDS-related Progressive Multifocal Leucoencephalopathy?

Who this might be right for
AIDSProgressive Multifocal Leucoencephalopathy (PML)
Fondation Ophtalmologique Adolphe de Rothschild 34
Not applicableLooking for participantsNCT06314958
What this trial is testing

Stage II/III Colorectal Cancer Recurrence

Who this might be right for
Colorectal CancerColorectal AdenocarcinomaColorectal Cancer Stage II+2 more
City of Hope Medical Center 400
Not applicableStudy completedNCT06525675
What this trial is testing

Study to Evaluate the Extended Overall Survival (OS) Data From PARSIFAL Study (The PARSIFAL-LONG Study)

Who this might be right for
Metastatic Breast CancerAdvanced Breast CancerLuminal Breast Cancer+2 more
MedSIR 419
Large-scale testing (Phase 3)Study completedNCT02980731
What this trial is testing

A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent).

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
AbbVie 210
Testing effectiveness (Phase 2)Looking for participantsNCT05286814
What this trial is testing

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Who this might be right for
Metastatic Colorectal Cancer (Mcrc)Intrahepatic Cholangiocarcinoma (Icc)Intrahepatic Bile Duct Cancer+10 more
National Cancer Institute (NCI) 70
Not applicableActive Not RecruitingNCT07448662
What this trial is testing

Local Treatment Strategies for Brain Metastases of Colorectal Cancer

Who this might be right for
Colorectal CancerBrain Metastases, Adult
Blokhin's Russian Cancer Research Center 700
Large-scale testing (Phase 3)Active Not RecruitingNCT03164616
What this trial is testing

Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).

Who this might be right for
Non Small Cell Lung Cancer NSCLC
AstraZeneca 1,186
Not applicableStudy completedNCT05968599
What this trial is testing

Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Pfizer 2,731
Large-scale testing (Phase 3)Study completedNCT01471444
What this trial is testing

Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Who this might be right for
Disorder Related to Bone Marrow TransplantationLeukemiaTransplantation Infection
M.D. Anderson Cancer Center 256
Not applicableStudy completedNCT05673967
What this trial is testing

Real-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma (RRMM)
Regeneron Pharmaceuticals 62
Not applicableWithdrawnNCT01778764
What this trial is testing

Phase I Compare OS in Post-CyberKnife Radiosurgery Tx in 1-3 VS 4 or More Brain Metastases

Who this might be right for
Brain and Nervous System
Stanford University
Not applicableLooking for participantsNCT04520672
What this trial is testing

Circulating Tumor Cells (CTC) in Cancer

Who this might be right for
Cancer
University Hospital, Basel, Switzerland 3,000
Not applicableUnknownNCT04331912
What this trial is testing

PFS and OS of Patients With Advanced Neuroendocrine Cancer (NEN) After Systemic Treatment

Who this might be right for
Neuroendocrine Tumors
University of Warmia and Mazury 100
Testing effectiveness (Phase 2)UnknownNCT04194125
What this trial is testing

Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine Cancer

Who this might be right for
Neuroendocrine Tumors
University of Warmia and Mazury 25
Not applicableActive Not RecruitingNCT07448493
What this trial is testing

Local Treatment Strategies for Brain Metastases of Gastric and Esophageal Cancer

Who this might be right for
Gastric CancerEsophageal CancerBrain Metastases
Blokhin's Russian Cancer Research Center 230
Testing effectiveness (Phase 2)UnknownNCT04029428
What this trial is testing

Peptide Receptor Radionuclide Therapy in the Treatment of Advanced, Non-resectable and/or Symptomatic Tumors With SSTR Overexpression

Who this might be right for
Neuroendocrine Tumors
University of Warmia and Mazury 150
Large-scale testing (Phase 3)Active Not RecruitingNCT02066220
What this trial is testing

International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma

Who this might be right for
Brain Tumors
Universitätsklinikum Hamburg-Eppendorf 360
Not applicableUnknownNCT03336554
What this trial is testing

Epigenetic Biomarker for Osteosarcoma

Who this might be right for
Histologic Response (Tumor Necrosis Rate)Objective Response Rate for Neoadjuvant Chemotherapy, ORRProgression-free Survival, PFS+1 more
Peking University People's Hospital 100
Not applicableLooking for participantsNCT07464470
What this trial is testing

Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Gastroesophageal Cancers

Who this might be right for
Gastric CancerEsophageal CancerBrain Metastases
Blokhin's Russian Cancer Research Center 30
Next Page